| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Göke K and Bunjes H | Carrier characteristics influence the kinetics of passive drug loading into lipid nanoemulsions. | 2018 | Eur J Pharm Biopharm | pmid:28807819 |
| Göke K and Bunjes H | Parameters influencing the course of passive drug loading into lipid nanoemulsions. | 2018 | Eur J Pharm Biopharm | pmid:28529070 |
| Nagy-Szakal D et al. | Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. | 2018 | Sci Rep | pmid:29968805 |
| Liu J et al. | The impact of particle preparation methods and polymorphic stability of lipid excipients on protein distribution in microparticles. | 2017 | Drug Dev Ind Pharm | pmid:28756687 |
| Roese E and Bunjes H | Drug release studies from lipid nanoparticles in physiological media by a new DSC method. | 2017 | J Control Release | pmid:28450207 |
| Göke K et al. | Control over Particle Size Distribution by Autoclaving Poloxamer-Stabilized Trimyristin Nanodispersions. | 2016 | Mol. Pharm. | pmid:27463039 |
| Muñoz de Escalona M et al. | Magnetic solid lipid nanoparticles in hyperthermia against colon cancer. | 2016 | Int J Pharm | pmid:26969080 |
| Even MP et al. | Impact of implant composition of twin-screw extruded lipid implants on the release behavior. | 2015 | Int J Pharm | pmid:26188320 |
| Strasdat B and Bunjes H | Development of a new approach to investigating the drug transfer from colloidal carrier systems applying lipid nanosuspension-containing alginate microbeads as acceptor. | 2015 | Int J Pharm | pmid:25943880 |
| Kupetz E and Bunjes H | Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles. | 2014 | J Control Release | pmid:24933601 |
| Christophersen PC et al. | Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation. | 2014 | Pharm. Res. | pmid:24623481 |
| Rao MP et al. | Bixin loaded solid lipid nanoparticles for enhanced hepatoprotection--preparation, characterisation and in vivo evaluation. | 2014 | Int J Pharm | pmid:25066077 |
| Dawoud M and Hashem FM | Comparative study on the suitability of two techniques for measuring the transfer of lipophilic drug models from lipid nanoparticles to lipophilic acceptors. | 2014 | AAPS PharmSciTech | pmid:25128298 |
| Lugemwa FN | Extraction of betulin, trimyristin, eugenol and carnosic acid using water-organic solvent mixtures. | 2012 | Molecules | pmid:22864237 |
| Severino P et al. | Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. | 2012 | J Drug Deliv | pmid:22175030 |
| Vaassen J et al. | Taste masked lipid pellets with enhanced release of hydrophobic active ingredient. | 2012 | Int J Pharm | pmid:22465412 |
| Jin SE et al. | Cellular delivery of cationic lipid nanoparticle-based SMAD3 antisense oligonucleotides for the inhibition of collagen production in keloid fibroblasts. | 2012 | Eur J Pharm Biopharm | pmid:22705642 |
| Joseph S and Bunjes H | Preparation of nanoemulsions and solid lipid nanoparticles by premix membrane emulsification. | 2012 | J Pharm Sci | pmid:22527807 |
| Noack A et al. | Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. | 2012 | Int J Pharm | pmid:22197758 |
| Di Sabatino M et al. | Spray congealed lipid microparticles with high protein loading: preparation and solid state characterisation. | 2012 | Eur J Pharm Sci | pmid:22465062 |
| Manjunath K et al. | Preparation and characterization of nitrendipine solid lipid nanoparticles. | 2011 | Pharmazie | pmid:21553647 |
| Petersen S et al. | The physical state of lipid nanoparticles influences their effect on in vitro cell viability. | 2011 | Eur J Pharm Biopharm | pmid:21458564 |
| MacDougall KM et al. | Triacylglycerol profiling of microalgae strains for biofuel feedstock by liquid chromatography-high-resolution mass spectrometry. | 2011 | Anal Bioanal Chem | pmid:21915640 |
| Thatipamula R et al. | Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers. | 2011 | Daru | pmid:22615636 |
| Huang Y et al. | Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. | 2011 | J. Biol. Chem. | pmid:21878620 |
| Li R et al. | Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration. | 2011 | Arch. Pharm. Res. | pmid:21380818 |
| Vallim T and Salter AM | Regulation of hepatic gene expression by saturated fatty acids. | 2010 Apr-Jun | Prostaglandins Leukot. Essent. Fatty Acids | pmid:20227267 |
| Pynn CJ et al. | Myristate is selectively incorporated into surfactant and decreases dipalmitoylphosphatidylcholine without functional impairment. | 2010 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:20811010 |
| Legrand P et al. | Short chain saturated fatty acids decrease circulating cholesterol and increase tissue PUFA content in the rat. | 2010 | Lipids | pmid:20924709 |
| Lahnsteiner F et al. | Composition and metabolism of carbohydrates and lipids in Sparus aurata semen and its relation to viability expressed as sperm motility when activated. | 2010 | Comp. Biochem. Physiol. B, Biochem. Mol. Biol. | pmid:20441800 |
| Seetapan N et al. | Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency. | 2010 | Drug Dev Ind Pharm | pmid:20184417 |
| Jaiswal P et al. | Enzyme Inhibition by Molluscicidal Components of Myristica fragrans Houtt. in the Nervous Tissue of Snail Lymnaea acuminata. | 2010 | Enzyme Res | pmid:21048864 |
| Nayak AP et al. | Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. | 2010 | Colloids Surf B Biointerfaces | pmid:20688493 |
| Martins S et al. | Improving oral absorption of Salmon calcitonin by trimyristin lipid nanoparticles. | 2009 | J Biomed Nanotechnol | pmid:20055109 |
| Bhaskar K et al. | Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics. | 2009 | Drug Dev Ind Pharm | pmid:18665979 |
| Krause J et al. | Immediate release pellets with lipid binders obtained by solvent-free cold extrusion. | 2009 | Eur J Pharm Biopharm | pmid:18805483 |
| Bhaskar K et al. | Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. | 2009 | Lipids Health Dis | pmid:19243632 |
| Royter M et al. | Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis. | 2009 | Extremophiles | pmid:19579003 |
| Kato T et al. | Alkane inducible proteins in Geobacillus thermoleovorans B23. | 2009 | BMC Microbiol. | pmid:19320977 |
| Karabulut I et al. | Fatty acid selectivity of lipases during acidolysis reaction between oleic acid and monoacid triacylglycerols. | 2009 | J. Agric. Food Chem. | pmid:19835376 |
| Mukherjee S et al. | Solid lipid nanoparticles: a modern formulation approach in drug delivery system. | 2009 | Indian J Pharm Sci | pmid:20502539 |
| Kawai M et al. | Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft. | 2009 | Breast Cancer Res. | pmid:19575785 |
| Tada M et al. | Myristic Acid, A Side Chain of Phorbol Myristate Acetate (PMA), Can Activate Human Polymorphonuclear Leukocytes to Produce Oxygen Radicals More Potently than PMA. | 2009 | J Clin Biochem Nutr | pmid:19902021 |
| Reitz C et al. | Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties. | 2008 | Eur J Pharm Sci | pmid:18765281 |
| Koennings S et al. | Confocal microscopy for the elucidation of mass transport mechanisms involved in protein release from lipid-based matrices. | 2007 | Pharm. Res. | pmid:17457662 |
| Butovich IA et al. | Lipids of human meibum: mass-spectrometric analysis and structural elucidation. | 2007 | J. Lipid Res. | pmid:17626978 |
| Sonesson AW et al. | Tracking single lipase molecules on a trimyristin substrate surface using quantum dots. | 2007 | Langmuir | pmid:17616159 |
| Sonesson AW et al. | Mobility of Thermomyces lanuginosus lipase on a trimyristin substrate surface. | 2007 | Langmuir | pmid:17261037 |
| Zhang J et al. | Cloning, expression, and characterization of a cold-adapted lipase gene from an antarctic deep-sea psychrotrophic bacterium, Psychrobacter sp 7195. | 2007 | J. Microbiol. Biotechnol. | pmid:18051271 |
| Karupaiah T and Sundram K | Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. | 2007 | Nutr Metab (Lond) | pmid:17625019 |
TRIMYRISTIN
TRIMYRISTIN is a lipid of Glycerolipids (GL) class. Trimyristin is associated with abnormalities such as METABOLIC DISTURBANCE, Hypertensive disease, Glucose Intolerance, Obesity and Cardiovascular Diseases. The involved functions are known as Signal, establishment and maintenance of localization, Saturated, Synthesis and Regulation. Trimyristin often locates in Hepatic, Protoplasm, Adipose tissue and Endoplasmic Reticulum. The associated genes with TRIMYRISTIN are chylomicron remnant, Fusion Protein, Alleles, Mutant Proteins and Genome, Human. The related lipids are Fatty Acids, Palmitates, dipalmitin, cholesteryl oleate and Nonesterified Fatty Acids.
Cross Reference
Introduction
To understand associated biological information of TRIMYRISTIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with TRIMYRISTIN?
TRIMYRISTIN is suspected in Fatty Liver, Non-alcoholic fatty liver, METABOLIC DISTURBANCE, Hypertensive disease, Glucose Intolerance, Obesity and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with TRIMYRISTIN
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with TRIMYRISTIN?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with TRIMYRISTIN?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with TRIMYRISTIN?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with TRIMYRISTIN?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with TRIMYRISTIN?
There are no associated biomedical information in the current reference collection.